XML 58 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies - Summary of Product Revenues by Product Line (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue from External Customer [Line Items]      
Revenue $ 632,362 $ 801,536 $ 670,534
Filtration Products [Member]      
Revenue from External Customer [Line Items]      
Revenue 341,379 [1] 495,930 403,505 [2]
Chromatography Products [Member]      
Revenue from External Customer [Line Items]      
Revenue 126,629 [1] 131,680 91,037 [2]
Process Analytics Products [Member]      
Revenue from External Customer [Line Items]      
Revenue 56,820 [1] 53,512 48,019 [2]
Proteins Products [Member]      
Revenue from External Customer [Line Items]      
Revenue 103,463 [1] 114,320 123,707 [2]
Other products [Member]      
Revenue from External Customer [Line Items]      
Revenue 3,688 [1] 5,741 4,051 [2]
Products      
Revenue from External Customer [Line Items]      
Revenue $ 631,979 [1] $ 801,183 $ 670,319 [2]
[1] 2023 revenue for filtration products includes revenue related to FlexBiosys, Inc. (“FlexBiosys”) from April 17, 2023, as well as Metenova Holding AB (“Metenova”) from October 2, 2023.
[2] 2021 revenue for filtration products includes revenue related to Polymem S.A. (“Polymem”) from July 1, 2021, as well as BioFlex Solutions LLC (“BioFlex”) and Newton T&M Corp. (“NTM”) from December 16, 2021 through December 31, 2021. 2021 revenue for proteins products includes revenue related to Avitide, Inc. (“Avitide”) from September 20, 2021 through December 31, 2021.